Arcellx, INC. (ACLX) SEC Filings — 2024
28 SEC filings for Arcellx, INC. (ACLX) in 2024.
Filings
- Arcellx, Inc. Files 8-K Report — 8-K · Dec 12, 2024
- Arcellx, Inc. Files 8-K: Corporate and Financial Update — 8-K · Dec 9, 2024
- Arcellx, INC. SC 13G Filing — SC 13G · Nov 22, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Rami Elghandour Files SC 13D for Arcellx, Inc. — SC 13D · Nov 8, 2024
- Arcellx, Inc. Files 8-K Report — 8-K · Nov 7, 2024
- Arcellx Q3 2024 Update: Clinical Progress & Financials — 10-Q · Nov 7, 2024
- Arcellx, Inc. Files 8-K Report — 8-K · Nov 5, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
- Arcellx, Inc. Files 8-K Report — 8-K · Aug 8, 2024
- Arcellx Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Arcellx, Inc. Files 8-K on Shareholder Vote Matters — 8-K · May 29, 2024
- Arcellx, Inc. Files 8-K for Operations and Financials — 8-K · May 9, 2024
- Arcellx, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Arcellx, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 11, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- SR One Capital Management Amends Arcellx Stake — SC 13D/A · Mar 25, 2024
- Arcellx Licenses CART-ddBCMA to Kite Pharma for $125M Upfront — 8-K · Mar 14, 2024
- Arcellx, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Arcellx, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC Discloses 8.994% Stake in Arcellx, Inc. — SC 13G · Feb 9, 2024
- Arcellx Terminates Material Definitive Agreement, Effective Jan 30 — 8-K · Jan 31, 2024
- BlackRock Discloses Significant Passive Stake in Arcellx, Inc. — SC 13G · Jan 29, 2024